Journal of Neural Transmission

, Volume 113, Issue 9, pp 1337–1346 | Cite as

Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus

  • S. Chiba
  • R. Hashimoto
  • S. Hattori
  • M. Yohda
  • B. Lipska
  • D. R. Weinberger
  • H. Kunugi
Article

Summary.

Altered expression of Disrupted-In-Schizophrenia-1 (DISC1) and dysbindin (DTNBP1), susceptibility genes for schizophrenia, in schizophrenic brain has been reported; however, the possible effect of antipsychotics on the expression levels of these genes has not yet been studied. We measured the mRNA expression levels of these genes in frontal cortex and hippocampus of mice chronically treated with typical and atypical antipsychotics by a real-time quantitative RT-PCR method. We found that atypical antipsychotics, olanzapine and risperidone, in a clinically relevant dose increased DISC1 expression levels in frontal cortex, while a typical antipsychotic, haloperidol, did not. No significant effect on dysbindin expression levels was observed in either brain region. These data suggest that prior evidence of decreased expression of dysbindin in postmortem brain of schizophrenics is not likely to be a simple artifact of antemortem drug treatment. Our results also suggest a potential role of DISC1 in the therapeutic mechanisms of certain atypical antipsychotics.

Keywords: Antipsychotic, DISC1, dysbindin, schizophrenia, gene expression. 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benson, MA, Newey, SE, Martin-Rendon, E, Hawkes, R, Blake, DJ 2001Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brainJ Biol Chem2762423224241PubMedCrossRefGoogle Scholar
  2. Callicott, JH, Straub, RE, Pezawas, L, Egan, MF, Mattay, VS, Hariri, AR, Verchinski, BA, Meyer-Lindenberg, A, Balkissoon, R, Kolachana, B, Goldberg, TE, Weinberger, DR 2005Variation in DISC1 affects hippocampal structure and function and increases risk for schizophreniaProc Natl Acad Sci USA10286278632PubMedCrossRefGoogle Scholar
  3. Ekelund, J, Hennah, W, Hiekkalinna, T, Parker, A, Meyer, J, Lonnqvist, J, Peltonen, L 2004Replication of 1q42 linkage in Finnish schizophrenia pedigreesMol Psychiatry910371041PubMedCrossRefGoogle Scholar
  4. Ekelund, J, Hovatta, I, Parker, A, Paunio, T, Varilo, T, Martin, R, Suhonen, J, Ellonen, P, Chan, G, Sinsheimer, JS, Sobel, E, Juvonen, H, Arajarvi, R, Partonen, T, Suvisaari, J, Lonnqvist, J, Meyer, J, Peltonen, L 2001Chromosome 1 loci in Finnish schizophrenia familiesHum Mol Genet1016111617PubMedCrossRefGoogle Scholar
  5. Funke, B, Finn, CT, Plocik, AM, Lake, S, DeRosse, P, Kane, JM, Kucherlapati, R, Malhotra, AK 2004Association of the DTNBP1 locus with schizophrenia in a U.S. populationAm J Hum Genet75891898PubMedCrossRefGoogle Scholar
  6. Harrison, PJ, Weinberger, DR 2005Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMol Psychiatry104068PubMedCrossRefGoogle Scholar
  7. Hashimoto, R, Straub, RE, Weickert, CS, Hyde, TM, Kleinman, JE, Weinberger, DR 2004Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophreniaMol Psychiatry9299307PubMedCrossRefGoogle Scholar
  8. Hennah, W, Varilo, T, Kestila, M, Paunio, T, Arajarvi, R, Haukka, J, Parker, A, Martin, R, Levitzky, S, Partonen, T, Meyer, J, Lonnqvist, J, Peltonen, L, Ekelund, J 2003Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effectsHum Mol Genet1231513159PubMedCrossRefGoogle Scholar
  9. Hodgkinson, CA, Goldman, D, Jaeger, J, Persaud, S, Kane, JM, Lipsky, RH, Malhotra, AK 2004Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorderAm J Hum Genet75862872PubMedCrossRefGoogle Scholar
  10. James R, Christie S, Buchanan SR, Porteous DJ, Millar JK (2004) Investigation of the cellular function of DISC1, a susceptibility gene for psychiatric illness. Program No 3476 2004 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DCGoogle Scholar
  11. Kapur, S, Wadenberg, ML, Remington, G 2000Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the benchCan J Psychiatry45241246PubMedGoogle Scholar
  12. Kirov, G, Ivanov, D, Williams, NM, Preece, A, Nikolov, I, Milev, R, Koleva, S, Dimitrova, A, Toncheva, D, O’Donovan, MC, Owen, MJ 2004Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from BulgariaBiol Psychiatry55971975PubMedCrossRefGoogle Scholar
  13. Li, W, Zhang, Q, Oiso, N, Novak, EK, Gautam, R, O’Brien, EP, Tinsley, CL, Blake, DJ, Spritz, RA, Copeland, NG, Jenkins, NA, Amato, D, Roe, BA, Starcevic, M, Dell’Angelica, EC, Elliott, RW, Mishra, V, Kingsmore, SF, Paylor, RE, Swank, RT 2003Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1)Nat Genet358489PubMedCrossRefGoogle Scholar
  14. Lipska, BK, Khaing, ZZ, Weickert, CS, Weinberger, DR 2001BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugsEur J Neurosci14135144PubMedCrossRefGoogle Scholar
  15. Lipska BK, Horowitz C, Peters T, Weickert CS, Hyde TM, Egan MF, Callicott JH, Straub RE, Kleinman JE, Weinberger DR (2004) Expression of DISC1 in schizophrenia. Program No 1098 2004 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DCGoogle Scholar
  16. McClintock W, Shannon Weickert C, Halim ND, Lipska BK, Hyde TM, Herman MM, Weinberger DR, Kleinman JE, Straub RE (2003) Reduced expression of dysbindin protein in the dorsolateral prefrontal cortex of patients with schizophrenia. Program No 3179 2003 Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DCGoogle Scholar
  17. Millar, JK, Christie, S, Porteous, DJ 2003Yeast two-hybrid screens implicate DISC1 in brain development and functionBiochem Biophys Res Commun31110191025PubMedCrossRefGoogle Scholar
  18. Millar, JK, Wilson-Annan, JC, Anderson, S, Christie, S, Taylor, MS, Semple, CA, Devon, RS, Clair, DM, Muir, WJ, Blackwood, DH, Porteous, DJ 2000Disruption of two novel genes by a translocation co-segregating with schizophreniaHum Mol Genet914151423PubMedCrossRefGoogle Scholar
  19. Miyoshi, K, Honda, A, Baba, K, Taniguchi, M, Oono, K, Fujita, T, Kuroda, S, Katayama, T, Tohyama, M 2003Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowthMol Psychiatry8685694PubMedCrossRefGoogle Scholar
  20. Morris, DW, McGhee, KA, Schwaiger, S, Scully, P, Quinn, J, Meagher, D, Waddington, JL, Gill, M, Corvin, AP 2003aNo evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based studySchizophr Res60167172CrossRefGoogle Scholar
  21. Morris, JA, Kandpal, G, Ma, L, Austin, CP 2003bDISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutationHum Mol Genet1215911608CrossRefGoogle Scholar
  22. Numakawa, T, Yagasaki, Y, Ishimoto, T, Okada, T, Suzuki, T, Iwata, N, Ozaki, N, Taguchi, T, Tatsumi, M, Kamijima, K, Straub, RE, Weinberger, DR, Kunugi, H, Hashimoto, R 2004Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophreniaHum Mol Genet1326992708PubMedCrossRefGoogle Scholar
  23. Owen, MJ, Williams, NM, O’Donovan, MC 2004The molecular genetics of schizophrenia: new findings promise new insightsMol Psychiatry91427PubMedCrossRefGoogle Scholar
  24. Ozeki, Y, Tomoda, T, Kleiderlein, J, Kamiya, A, Bord, L, Fujii, K, Okawa, M, Yamada, N, Hatten, ME, Snyder, SH, Ross, CA, Sawa, A 2003Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowthProc Natl Acad Sci USA100289294PubMedCrossRefGoogle Scholar
  25. Parikh, V, Terry, AV, Khan, MM, Mahadik, SP 2004Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapinePsychopharmacology (Berl)172365374CrossRefGoogle Scholar
  26. Sawamura, N, Sawamura-Yamamoto, T, Ozeki, Y, Ross, CA, Sawa, A 2005A form of DISC1 enriched in nucleus: altered subcellular distribution in orbitofrontal cortex in psychosis and substance/alcohol abuseProc Natl Acad Sci USA10211871192PubMedCrossRefGoogle Scholar
  27. Schwab, SG, Knapp, M, Mondabon, S, Hallmayer, J, Borrmann-Hassenbach, M, Albus, M, Lerer, B, Rietschel, M, Trixler, M, Maier, W, Wildenauer, DB 2003Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad familiesAm J Hum Genet72185190PubMedCrossRefGoogle Scholar
  28. Straub, RE, Jiang, Y, MacLean, CJ, Ma, Y, Webb, BT, Myakishev, MV, Harris-Kerr, C, Wormley, B, Sadek, H, Kadambi, B, Cesare, AJ, Gibberman, A, Wang, X, O’Neill, FA, Walsh, D, Kendler, KS 2002Genetic variation in the 6p22.3 Gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophreniaAm J Hum Genet71337348PubMedCrossRefGoogle Scholar
  29. Talbot, K, Eidem, WL, Tinsley, CL, Benson, MA, Thompson, EW, Smith, RJ, Hahn, CG, Siegel, SJ, Trojanowski, JQ, Gur, RE, Blake, DJ, Arnold, SE 2004Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophreniaJ Clin Invest11313531363PubMedCrossRefGoogle Scholar
  30. Tang, JX, Zhou, J, Fan, JB, Li, XW, Shi, YY, Gu, NF, Feng, GY, Xing, YL, Shi, JG, He, L 2003Family-based association study of DTNBP1 in 6p22.3 and schizophreniaMol Psychiatry8717718PubMedCrossRefGoogle Scholar
  31. Van Den Bogaert, A, Schumacher, J, Schulze, TG, Otte, AC, Ohlraun, S, Kovalenko, S, Becker, T, Freudenberg, J, Jonsson, EG, Mattila-Evenden, M, Sedvall, GC, Czerski, PM, Kapelski, P, Hauser, J, Maier, W, Rietschel, M, Propping, P, Nothen, MM, Cichon, S 2003The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the diseaseAm J Hum Genet7314381443PubMedCrossRefGoogle Scholar
  32. van den Oord, EJ, Sullivan, PF, Jiang, Y, Walsh, D, O’Neill, FA, Kendler, KS, Riley, BP 2003Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia familiesMol Psychiatry8499510PubMedCrossRefGoogle Scholar
  33. Weickert, CS, Straub, RE, McClintock, BW, Matsumoto, M, Hashimoto, R, Hyde, TM, Herman, MM, Weinberger, DR, Kleinman, JE 2004Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrainArch Gen Psychiatry61544555PubMedCrossRefGoogle Scholar
  34. Williams, NM, Preece, A, Morris, DW, Spurlock, G, Bray, NJ, Stephens, M, Norton, N, Williams, H, Clement, M, Dwyer, S, Curran, C, Wilkinson, J, Moskvina, V, Waddington, JL, Gill, M, Corvin, AP, Zammit, S, Kirov, G, Owen, MJ, O’Donovan, MC 2004Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1)Arch Gen Psychiatry61336344PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • S. Chiba
    • 1
    • 2
  • R. Hashimoto
    • 1
  • S. Hattori
    • 1
  • M. Yohda
    • 2
  • B. Lipska
    • 3
  • D. R. Weinberger
    • 3
  • H. Kunugi
    • 1
  1. 1.Department of Mental Disorder Research, National Institute of NeuroscienceNational Center of Neurology and PsychiatryKodairaJapan
  2. 2.Department of Biotechnology and Life ScienceTokyo University of Agriculture and TechnologyKoganeiJapan
  3. 3.Clinical Brain Disorders BranchNational Institute of Mental Health, National Institutes of HealthBethesdaUSA

Personalised recommendations